Women's preferences for vaginal antimicrobial contraceptives III - Choice of a formulation, applicator, and packaging

dc.creatorHardy, E
dc.creatorJimenez, AL
dc.creatorde Padua, KS
dc.creatorZaneveld, LJD
dc.date1998
dc.dateOCT
dc.date2014-12-02T16:27:25Z
dc.date2015-11-26T16:34:06Z
dc.date2014-12-02T16:27:25Z
dc.date2015-11-26T16:34:06Z
dc.date.accessioned2018-03-28T23:16:15Z
dc.date.available2018-03-28T23:16:15Z
dc.identifierContraception. Elsevier Science Inc, v. 58, n. 4, n. 245, n. 249, 1998.
dc.identifier0010-7824
dc.identifierWOS:000077465600009
dc.identifier10.1016/S0010-7824(98)00104-8
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/72906
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/72906
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/72906
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1271093
dc.descriptionNovel vaginal formulations are under development to combat the increasing incidence of sexually transmitted diseases, including AIDS, and also unplanned pregnancies. A study was performed to determine women's preferences for different dosage forms (gel, cream, ovule/suppository, film, foam, tablet), width, length, and color of an applicator, and Various types of packages. The study was conducted in Campinas, Brazil. A total of 635 women were interviewed including both adolescents and adults and low and middle-high socioeconomic groups. The large majority of the women preferred a gel over a cream; both were preferred over the other methods. When asked which method they would not use, the film was most frequently identified, followed by the tablet and ovule. The primary reasons for selecting a particular dosage form were ease of use, absence of odor or the presence of a pleasant one, absence of color, and insertion with an applicator. The major reasons for not using a method were discomfort, "plastic" appearance, distrust of effectiveness, difficulty with insertion, messiness, and rigidity/hardness. The majority of the women liked the applicator shown. The prefilled single dose applicator was by far the preferred packaging. This information should aid in the development of consumer-friendly vaginal formulations. (C) 1998 Elsevier Science Inc. All rights reserved.
dc.description58
dc.description4
dc.description245
dc.description249
dc.languageen
dc.publisherElsevier Science Inc
dc.publisherNew York
dc.publisherEUA
dc.relationContraception
dc.relationContraception
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectvaginal formulation
dc.subjectcontraception
dc.subjectsexually transmitted diseases
dc.subjectAIDS
dc.subjectpackaging
dc.subjectapplicator
dc.subjectmarket research
dc.subjectNonoxynol-9
dc.subjectAcceptability
dc.titleWomen's preferences for vaginal antimicrobial contraceptives III - Choice of a formulation, applicator, and packaging
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución